<-- test --!> Health and Fitness – Page 586 – Best Reviews By Consumers

Health and Fitness

Patagonia Nano Puff Jacket Cyber Week Sale: Take up to 54% Off at Dick’s Sporting Goods

Our product picks are editor-tested, expert-approved. We may earn a commission through links on our site. Why Trust Us? Black Friday is behind us, but the deluge of Cyber Week sales continue. Between us, a lot of them aren’t so great, which is why our commerce team is always scanning the internet for great sales …

Patagonia Nano Puff Jacket Cyber Week Sale: Take up to 54% Off at Dick’s Sporting Goods Read More »

Analytics and risk management saves Franciscan Alliance $2.2M

With care management and engagement tools, the Franciscan Alliance healthcare ministry was able to generate $2.2 million in savings across multiple Medicare and Medicare Advantage plans, according to an announcement Wednesday. The Franciscan health system leveraged the Innovaccer platform to reduce readmissions, automate emergency department workflows and improve the patient experience, the company said. Creating …

Analytics and risk management saves Franciscan Alliance $2.2M Read More »

How behavioral healthcare can benefit from patient portals

Some behavioral healthcare practices have begun advancing their patient portal and mobile app offerings. Native telehealth integration was a rarity in patient portals not too long ago. But it has become more common since the COVID-19 pandemic – and this trend is likely to continue. After telehealth appointments, patient portals can grant access to information about self-care …

How behavioral healthcare can benefit from patient portals Read More »

Cybersecurity frameworks in APAC don’t support remote care: report

Existing cybersecurity frameworks for healthcare across Asia-Pacific are not suited for remote care management.  This is based on a new report by the Asia Pacific Medical Technology Association (APACMed) and L.E.K. Consulting which looked into the cybersecurity landscape of the region and how policies and other measures apply in the rising remote care segment.  WHY …

Cybersecurity frameworks in APAC don’t support remote care: report Read More »

Kerendia™ (finerenone) granted expanded indication in the EU for broad range of patients with chronic kidney disease and type 2 diabetes

Not intended for U.S. and UK Media Berlin, February 10, 2023 – The European Commission granted approval for a label extension for Kerendia™ (finerenone) in the European Union (EU) to include results on cardiovascular (CV) outcomes from the Phase III FIGARO-DKD study. The study demonstrated that Kerendia reduced the risk of CV events in a …

Kerendia™ (finerenone) granted expanded indication in the EU for broad range of patients with chronic kidney disease and type 2 diabetes Read More »

Bayer submits aflibercept 8 mg for regulatory approval in two major retinal eye diseases in the EU

06 February 2023 | 10:59 AM Europe/Amsterdam Not intended for U.S. and UK Media Summary Filing for aflibercept 8 mg in neovascular (wet) age-related macular degeneration (nAMD) and diabetic macular edema (DME) is based on positive results of clinical trials, PULSAR and PHOTON / In both trials, aflibercept 8 mg demonstrated unprecedented durability results with …

Bayer submits aflibercept 8 mg for regulatory approval in two major retinal eye diseases in the EU Read More »

Bayer to distribute pheromone-based biological crop protection solutions from M2i Group

31 January 2023 | 08:59 AM Europe/Amsterdam 2023-0021 Pheromone-based crop protection products help farmers control pests in an environmentally friendly way Summary Biological pheromones present a non-toxic, innovative opportunity for biological crop protection while safeguarding biodiversity and beneficial pollinators / M2i’s patented bio-sourced micro-encapsulation technology means long-lasting pheromone controls with no residues and no plastic …

Bayer to distribute pheromone-based biological crop protection solutions from M2i Group Read More »

CHMP recommends Bayer’s darolutamide for the treatment of metastatic hormone-sensitive prostate cancer

Not intended for U.S. and UK Media Berlin, January 27, 2023 – The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has recommended darolutamide, an oral androgen receptor inhibitor (ARi), plus ADT in combination with docetaxel for marketing authorization in the European Union (EU) for the treatment of patients with …

CHMP recommends Bayer’s darolutamide for the treatment of metastatic hormone-sensitive prostate cancer Read More »